Cargando…
A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody‐antigen system
Hepatocellular carcinoma (HCC) is a malignancy with a dismal survival rate. The novel autoantibodies panel may provide new insights for the diagnosis of HCC. Biomarkers screened by two methods (bioinformatics and the antigen‐antibody system) were taken as candidate tumor‐associated antigens (TAAs)....
Autores principales: | Wu, Jinyu, Wang, Peng, Han, Zhuo, Li, Tiandong, Yi, Chuncheng, Qiu, Cuipeng, Yang, Qian, Sun, Guiying, Dai, Liping, Shi, Jianxiang, Wang, Keyan, Ye, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819288/ https://www.ncbi.nlm.nih.gov/pubmed/34821436 http://dx.doi.org/10.1111/cas.15217 |
Ejemplares similares
-
Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
por: Yang, Qian, et al.
Publicado: (2023) -
Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019) -
Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes
por: Wang, Keyan, et al.
Publicado: (2020) -
Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020)